• Publications
  • Influence
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Background— Three types of anthracycline-induced cardiotoxicities are currently recognized: acute, early-onset chronic, and late-onset chronic. However, data supporting this classification areExpand
  • 527
  • 23
  • PDF
Pulsed Dose-Rate Perioperative Interstitial Brachytherapy for Soft Tissue Sarcomas of the Extremities and Skeletal Muscles of the Trunk
BackgroundThis study evaluated the role of pulsed dose-rate (PDR) brachytherapy (BRT), delivered alone or as a boost to external beam radiotherapy, as adjuvant therapy for the local control of softExpand
  • 14
  • 2
Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach
Electroporation uses pulsed, high‐intensity electric fields to temporarily increase cell membrane permeability by creation of pores, through which small molecules, such as chemotherapeutic agents,Expand
  • 113
  • 1
Response to Letters Regarding Article, "Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy".
We appreciate the thoughtful comments of Patane, Gallucci, and coworkers regarding our study.1 The aim of our clinical study was to prospectively evaluate the incidence, timing of occurrence,Expand
  • 5
  • PDF
Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial
Objective: We performed a prospective, randomized clinical study to assess whether prophylactic treatment with metoprolol or losartan, initiated soon after lung cancer surgery in patients withExpand
  • 3
  • PDF
Newly identified tumor antigens as promising cancer vaccine targets for malignant melanoma treatment.
Immunogenicity of tumour cells, immunomodulation and direct targeting of signalling pathways are promising avenues and matter of dated and innovative research in melanoma. Unfortunately, tumour cellsExpand
  • 8
QTc interval evaluation in patients receiving anticancer drugs: Preliminary results of a retrospective study.
e19605 Background: Most anticancer therapies (ACT) may prolong the QT interval, increasing the risk of serious ventricular arrhythmias and sudden death. Moreover, oncologic patients are considered atExpand